Science Explorer Interactive view Map
Company · Basel · Switzerland

Boehringer Ingelheim (Switzerland)

boehringer-ingelheim.chROR OpenAlex
Research works
66
▲ 39% vs 2013–17
Citations
1.7k
25.2 per fractional work
Top-10% rate
9.7%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: Boehringer Ingelheim (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.16× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 6.49× its world share, 1 worksImmunology and Micro…Neuroscience: 2.00× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 16.39× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.66× its world share, 0 worksChemistryComputer Science: 0.16× its world share, 0 worksComputer ScienceEngineering: 0.14× its world share, 0 worksEngineeringEnvironmental Science: 0.40× its world share, 0 worksEnvironmental ScienceMedicine: 2.24× its world share, 5 worksMedicineVeterinary: 7.23× its world share, 0 worksVeterinaryDecision Sciences: 1.02× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.69× its world share, 0 worksEconomics, Econometr…Psychology: 0.16× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 16.4×. Every wedge is a field page.

Which keywords describe research at Boehringer Ingelheim (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Fibrosis, Oxidative Stress, Treatment, Metabolic Regulation, Pharmacokinetics, ATP-dependent Transporters and Multidrug Resistance.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation7▲ 4.5×29 topics
  2. Oxidative Stress4▲ 3.5×16 topics
  3. Fibrosis4▲ 32×5 topics
  4. Treatment4▲ 4.5×10 topics
  5. Cardiovascular Disease3▲ 4.0×11 topics
  6. Metabolic Regulation3▲ 14×3 topics
  7. Pharmacokinetics2▲ 14×3 topics
  8. ATP-dependent Transporters2▲ 66×1 topic
  9. Hypertension2▲ 9.6×6 topics
  10. Multidrug Resistance2▲ 57×1 topic
  11. Autoantibodies2▲ 14×3 topics
  12. Cytochrome P4502▲ 45×2 topics
  13. Interstitial Lung Disease2▲ 60×2 topics
  14. Cell Signaling2▲ 9.6×7 topics
  15. Metabolic Syndrome2▲ 3.7×8 topics
  16. Endothelial Dysfunction2▲ 10×2 topics
  17. Epithelial-Mesenchymal Transition2▲ 34×2 topics
  18. Drug Metabolism2▲ 51×2 topics
  19. Genetic Variation2▲ 9.1×2 topics
  20. TGF-ß Signaling2▲ 42×3 topics
  21. Enzyme Activities2▲ 68×1 topic
  22. Global Burden2▲ 5.1×3 topics
  23. Idiopathic Pulmonary Fibrosis2▲ 71×1 topic
  24. Pharmacogenetics2▲ 68×1 topic
  25. Pulmonary Involvement2▲ 83×1 topic
  26. Systemic Sclerosis2▲ 83×1 topic
  27. TGF-ß2▲ 16×1 topic
  28. Alzheimer's Disease2▲ 9.4×5 topics
  29. Drug Discovery2▲ 6.5×3 topics
  30. Teratogenicity2▲ 39×2 topics
  31. Cognitive Function2▲ 12×2 topics
  32. Lab-on-a-Chip2▲ 17×3 topics
  33. Bone Health2▲ 21×2 topics
  34. 3D Printing1▲ 11×2 topics
  35. Biomedical Research1▲ 27×1 topic
  36. COPD1▲ 32×1 topic
  37. Mass Spectrometry1▲ 9.6×3 topics
  38. Pharmacology1▲ 6.6×4 topics
  39. Poly(dimethylsiloxane)1▲ 42×1 topic
  40. spirometry1▲ 32×1 topic

Which research topics does Boehringer Ingelheim (Switzerland) publish most on?

By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Drug Transport and Resistance Mechanisms, Metabolomics and Mass Spectrometry Studies and Immunotherapy and Immune Responses.

Interstitial Lung Diseas…1Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 1 fractional worksDrug Transport and Resis…0Drug Transport and Resistance Mechanisms: 0 fractional worksMetabolomics and Mass Spectrometry Studies: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksDigestive system and related health: 0 fractional worksAdvanced Glycation End Products research: 0 fractional worksDementia and Cognitive Impairment Research: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksCAR-T cell therapy research: 0 fractional worksImmune Cell Function and Interaction: 0 fractional works
Pulmonary and Respiratory MedicineOncologyMolecular BiologyImmunology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
  2. 2 Drug Transport and Resistance Mechanisms Oncology 0 works
  3. 3 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
  4. 4 Immunotherapy and Immune Responses Immunology 0 works
  5. 5 Digestive system and related health Genetics 0 works
  6. 6 Advanced Glycation End Products research Clinical Biochemistry 0 works
  7. 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
  8. 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  9. 9 CAR-T cell therapy research Oncology 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.5%not open55.5%

World: 28% of research is openly available.

with international co-authors69.6%domestic only30.4%

World: 19% is written across borders.

How has Boehringer Ingelheim (Switzerland)'s research output changed?

Output in 2018–2022 was 39% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Basel

All research institutions in Basel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.